Patients Say GLP-1 Medicines Work Best Alongside Lifestyle Changes
16 Jun 2026
Researchers are now calling for clearer guidelines and better patient education to help manage expectations and improve support throughout treatment.
What Patients Reported
The study explored the experiences of people using GLP-1 medications, such as semaglutide, for weight management.
One of the strongest findings was that many patients experienced less "food noise" — the constant thoughts about food and hunger that can make weight management difficult.
Participants said the medication helped them make healthier choices and stay motivated with exercise and lifestyle changes.
Not a “Magic Fix”
Researchers found that patients generally did not see GLP-1 medicines as a miracle treatment.
Instead, many described them as a tool that worked best when combined with:
- healthy eating habits
- regular physical activity
- long-term lifestyle changes
Many participants reported feeling more confident and motivated to engage in activities that supported their health goals.
Need for Better Patient Support
The study highlighted major differences in the quality of care patients received.
Some participants said they were given detailed information and support, while others reported receiving prescriptions with little discussion about:
- possible side effects
- treatment expectations
- ongoing monitoring
Researchers noted that limited counselling sometimes delayed recognition of medication-related side effects.
Calls for Clearer Guidelines
Experts are recommending more consistent approaches to patient education and clinical support when prescribing GLP-1 medicines.
They believe standardised guidance could help:
- improve patient understanding
- support informed decision-making
- encourage safe and effective use of the medications
- manage expectations about weight-loss outcomes
GP Perspective
RACGP representative Dr Gary Deed said GLP-1 medicines are an important option for some patients but should always be part of a broader treatment plan.
He emphasised that lifestyle measures remain the foundation of successful weight management and that medications work best when combined with ongoing support from healthcare professionals.
Dr Deed also highlighted the need for resources that are accessible to culturally diverse and First Nations communities.
Looking Ahead
The findings come as the Australian Government considers advice on expanding access to semaglutide for certain patients through the Pharmaceutical Benefits Scheme (PBS).
Researchers say improving access, education, and long-term support will be important to achieving better health outcomes for people living with obesity and related health conditions.
Patients Say GLP-1 Medicines Work Best Alongside Lifestyle Changes
Source: newsGP, based on a 2026 study of patient experiences with GLP-1 receptor agonists (GLP-1 RAs)